Dutch Beverage Stock News

This article looks at whether CVC Capital Partners shares might be starting to look like value after a difficult period, by exploring what the current price could be implying about the company. The stock last closed at €11.32, with returns of a 4.5% decline over 7 days, an 11.8% decline over 30 days, a 19.3% decline year to date, and a 38.5% decline over the past year, which may have influenced how investors view both its potential and its risks. Recent coverage has examined how CVC Capital...

China expansion puts Aegon in focus Aegon (ENXTAM:AGN) is back on investors’ radar after launching Aegon Insurance Asset Management Company in Shanghai, a wholly owned unit that gives it direct access to long-term investments in China. The new license lets Aegon target areas such as infrastructure and renewable energy within China’s regulated insurance asset management market. This development could influence how investors think about the group’s future capital deployment and risk...

How Aalberts Stock Has Been Performing Recently Aalberts (ENXTAM:AALB) has moved lower in the very short term, with a 1 day decline of about 1% and a 7 day decline of about 1.4%, drawing fresh attention from investors. Over the past month the share price shows a decline of about 10%. Over the past 3 months it shows a gain of roughly 11%, offering a mixed picture for recent traders and for longer holding periods. See our latest analysis for Aalberts. With the share price at €31.42, Aalberts...

At Mobile World Congress in March 2026, Twilio announced a partnership with KPN Netherlands and Google to roll out nationwide Rich Communication Services (RCS) Business Messaging across all major Dutch mobile operators, with Android support at launch and broader device coverage expected in 2026. This collaboration places KPN at the core of the Netherlands’ business messaging infrastructure, enabling enterprises to use richer, measurable and verified communications within native messaging...

In February 2026, the Amsterdam District Court issued an interim judgment in Macedonian Thrace Brewery’s long-running damages case against Heineken and Athenian Brewery, accepting MTB’s expert model and indicating principal damages of at least €43.00 million, with total awards including interest expected to exceed €83.00 million once finalized. Around the same time, Heineken advanced its push into non-alcoholic beer with the launch of Heineken 0.0 Ultimate in select U.S. states, introducing...

Prosus (ENXTAM:PRX) jumped in early European trading after a sharp move higher in Tencent Holdings, as investors reacted to a U.S. presidential statement that hinted at possible easing of tensions in the Iran conflict. See our latest analysis for Prosus. Beyond today’s reaction to Tencent, Prosus has a 7.6% 1 year total shareholder return and a 57.8% 3 year total shareholder return, despite a 13.4% year to date share price decline. This suggests recent momentum has been rebuilding after a...

If you are wondering whether Aalberts is fairly priced or offering value at its recent share price, this article will walk through what the numbers actually say rather than relying on headlines or hype. The stock last closed at €31.76, with a 7 day return of a 4.5% decline, a 30 day return of a 9.8% decline, a year to date return of 11.4%, and a 1 year return of a 2.5% decline. Taken together, this gives you a mixed picture of recent momentum and shifting risk appetite. Recent coverage has...

How Wereldhave’s recent share performance frames the current valuation debate Wereldhave (ENXTAM:WHA) has drawn attention after a year total return of 45.7%, alongside a past 3 months gain of 12.1%, even as the share price has seen a 3% decline over the past month. For investors tracking consistency rather than short term price moves, the 3 year total return of 89.3% and 5 year total return of 105.1% sit against current annual revenue of €215.859m and net income of €73.344m. See our latest...

In recent months, ASML Holding has reinforced its EUV lithography leadership, secured continued reliance from major chipmakers, reported record bookings, and outlined new leadership appointments and capital return plans following its 2025 performance. At the same time, ASML is moving into advanced packaging and hybrid bonding tools while Chinese efforts to build rival EUV capabilities face substantial technological and supply chain hurdles. Now we will examine how ASML’s push into hybrid...

Recent performance snapshot Without a specific headline event driving attention today, Koninklijke Philips (ENXTAM:PHIA) may still interest you if you are tracking healthcare names with mixed short term and longer term return profiles. The stock shows a 0.9% decline over the past day and a 2.0% decline over the past week, with a larger 8.4% drop over the past month, while the past 3 months reflect a 7.3% gain. See our latest analysis for Koninklijke Philips. At a share price of €24.41, the...

CVC Capital Partners (ENXTAM:CVC) is back in focus after its 2025 earnings release, where record realisations and profit met a sharp reset in performance fee guidance that weighed on investor sentiment. See our latest analysis for CVC Capital Partners. The share price reaction around the 2025 results sits within a tougher year overall, with a 90 day share price return of 21.89% and a 1 year total shareholder return decline of 40.23%, suggesting momentum has been fading despite ongoing...

Sif Holding (ENXTAM:SIFG) has put fresh numbers on the table for FY 2025, with first half revenue of €258.2 million and a basic EPS loss of €0.91, setting a clear tone for where profitability currently stands. The company has seen revenue move from €230.98 million and EPS of €0.21 in the first half of 2024 to €198.0 million and an EPS loss of €0.36 in the second half of 2024, before landing at the latest half-year print. This keeps the focus firmly on how margins are holding up through this...

If you are wondering whether DSM-Firmenich at around €59 still reflects its true worth, you are not alone, and this article is built to help you assess what that price might really represent. The stock has been through a rough patch, with the share price down 14.6% over the last 30 days and 37.4% over the past year. It is up 2.9% over the past week and down 14.3% year to date. Recent coverage around DSM-Firmenich has focused on its position in the broader materials and specialty ingredients...

Event overview and why it matters Arcadis (ENXTAM:ARCAD) has secured two new contracts with the City of Los Angeles, covering work on the Los Angeles Convention Center Modernization and Expansion and the Department of Public Works Bureau of Engineering's Clean Water Program. The combined contract value exceeds €18 million, with €11 million tied to project and construction management support on the €2.5b convention center scheme and €7.5 million over five years for three stormwater initiatives...

Aalberts has completed the divestment of BROEN A/S, advancing its ‘thrive 2030’ repositioning plan. The company is running a significant share buyback programme alongside the transaction. ENXTAM:AALB last closed at €32.78. For you as an ENXTAM:AALB watcher, these moves relate directly to how Aalberts is reshaping its portfolio and capital structure. The share price stands at €32.78, with a 14.9% gain year to date and a 3.5% return over 1 year, while 3 year and 5 year returns show declines...

Basic-Fit (ENXTAM:BFIT) has wrapped up FY 2025 with second half revenue of €743.2 million and basic EPS of €0.34, alongside trailing 12 month revenue of €1.42 billion and basic EPS of €0.22. These figures frame the latest numbers in a broader earnings upswing. The company has seen revenue move from €630.44 million in the second half of 2024 to €743.2 million in the second half of 2025, while basic EPS shifted from €0.06 to €0.34 over the same periods. This sets up a story where higher sales...

Pharming Group (ENXTAM:PHARM) has wrapped up FY 2025 with fourth quarter revenue of US$106.5 million and basic EPS of US$0.008, while trailing twelve month figures stand at US$376.1 million in revenue and basic EPS of US$0.004. This frames a year where profitability on a full year basis edges into positive territory. The company has seen quarterly revenue move from US$92.7 million in Q4 2024 and US$74.8 million in Q3 2024 to US$106.5 million in Q4 2025. Over the same period, quarterly basic...

Envipco Holding (ENXTAM:ENVI) has reported its FY 2025 results with fourth quarter revenue of €23.8 million and a basic EPS loss of €0.03, while trailing twelve month revenue stands at €90.4 million with a full year basic EPS loss of €0.18. Over recent quarters the company has seen revenue move between €21.0 million and €23.8 million per quarter, while quarterly basic EPS losses have ranged from €0.03 to €0.07. This sets the scene for a story where strong reported revenue growth meets...

CVC Capital Partners (ENXTAM:CVC) has put up a punchy set of FY 2025 numbers, with first half revenue at €843.0 million and basic EPS of €0.54, set against trailing twelve month revenue of €1.85 billion and EPS of €1.11 that came with a very large year-on-year earnings increase and a net profit margin of 63.8% versus 14.4% the prior year. Over the past three reported halves, revenue has moved from €635.7 million with EPS of €0.05 in 1H 2024 to €926.2 million and EPS of €0.17 in 2H 2024,...

ABN AMRO Bank (ENXTAM:ABN) has released its 2025 Annual Report, giving investors fresh detail on value creation, capital allocation, cost efficiency, and sustainability commitments during a period of geopolitical and economic challenges. See our latest analysis for ABN AMRO Bank. At a share price of €28.25, ABN AMRO Bank has seen a 1-day share price return of 1.36% and a 7-day share price return of 1.07%. Its 30-day share price return of 10.26% and year to date share price return of 6.58%...

If you are wondering whether CSG is attractively priced or just a value trap, this article walks through what the numbers are really saying about the stock. CSG shares last closed at €29.43, with returns of a 4.4% decline over the past week, an 8.5% decline over the last month, and a 10.4% decline year to date, which may have caught the eye of investors watching for changing risk and return profiles. Recent coverage around CSG has focused on its overall positioning and fundamentals, giving...

Royal Philips recently expanded its digital pathology portfolio with a fully cloud-enabled IntelliSite Pathology Solution on HealthSuite, powered by Amazon Web Services, to help laboratories scale digital diagnostics, streamline workflows, and support remote, collaborative case review. An interesting angle is how this move deepens Philips’ role in AI-ready, interoperable diagnostic platforms across radiology, cardiology, and pathology, reinforcing its push into end-to-end, cloud-based...

If you are wondering whether ArcelorMittal shares still offer value after a strong run, this article will walk through what the current price might be telling you. The stock trades at €49.46 after a 1.8% decline over the last 7 days and 3.4% decline over the last 30 days. The year to date return is 24.1% and the 1 year return is 75.2%, with 90.1% over 3 years and 134.4% over 5 years. Recently, news coverage has focused on ArcelorMittal in the context of broader materials and steel sector...

Fugro N.V. has reported full-year 2025 results showing sales of €1,848.1 million and a net loss of €20.5 million, while also announcing that Chief Financial Officer and Board of Management member Barbara Geelen will step down after the April 23, 2026 AGM and remain as an adviser until August 1, 2026. The combination of a swing from profit to loss and the upcoming CFO transition raises questions about how Fugro balances investment, cost control, and financial leadership as it pursues growth...